Brevicompanine E reduces lipopolysaccharide-induced production of proinflammatory cytokines and enzymes in microglia by inhibiting activation of activator protein-1 and nuclear factor-κB
Xinying Yang(Shandong University), Hyun Park(Korea University), Suk‐Yul Jung(Namseoul University), Lin Du(Guiyang Medical University), Qianqun Gu(Ocean University of China), Byoung Yul Soh(National University of Singapore), Bing Zheng, Xuelian Tang(University of Jinan), Sung-Yeon Kim(Wonkwang University)
Cited by 18
Related Papers
Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
|Nature Medicine|2011|351
Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection
|Cancer Research|2009|248
STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma
|Cancer Letters|2012|193
Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition
|International Journal of Molecular Sciences|2016|190